PSMD10 and hepatocellular carcinoma: Gankyrin was identified as an oncoprotein that frequently overexpressed in human liver cancers and increased in the earlier stage of liver carcinogenesis.5, 6 It controls phosphorylated Rb and p53 degradation,7, 8 promotes the expansion of tumor-initiating cells9 and accelerates HCC progression.